Transdermal drug delivery: Clinical aspects

Y. N. Kalia; V. Merino; R. H. Guy

doi:10.1016/S0733-8635(05)70011-5

Transdermal drug delivery: Clinical aspects

Y. N. Kalia, V. Merino, R. H. Guy

Research output: Contribution to journal › Article › peer-review

58 Citations (SciVal)

Abstract

The delivery of drugs into and through the skin is a recognized and effective means of therapy for dermatologic, regional, and systemic disease. The selection of drug candidates and the rational design of suitable formulations depends upon the biological make-up of the skin's barrier, and the physicochemical interactions between the membrane, the delivery system technology, and the active agent. This article summarizes the state of the art and examines more recent developments that are the subject of considerable research at this time. In addition, the potential to use the skin as a portal for noninvasive clInical chemistry (e.g., for glucose monitoring in diabetics) is discussed.

Original language	English
Pages (from-to)	289-299
Number of pages	11
Journal	Dermatologic Clinics
Volume	16
Issue number	2
DOIs	https://doi.org/10.1016/S0733-8635(05)70011-5
Publication status	Published - 1 Apr 1998

Bibliographical note

Funding Information:
Financial support was provided by Novartis (Basel), Becton-Dickinson, and Electricité de France.

ASJC Scopus subject areas

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0733-8635(05)70011-5

Cite this

@article{817d3a91a50243e69ba830b6e0118798,

title = "Transdermal drug delivery: Clinical aspects",

abstract = "The delivery of drugs into and through the skin is a recognized and effective means of therapy for dermatologic, regional, and systemic disease. The selection of drug candidates and the rational design of suitable formulations depends upon the biological make-up of the skin's barrier, and the physicochemical interactions between the membrane, the delivery system technology, and the active agent. This article summarizes the state of the art and examines more recent developments that are the subject of considerable research at this time. In addition, the potential to use the skin as a portal for noninvasive clInical chemistry (e.g., for glucose monitoring in diabetics) is discussed.",

author = "Kalia, {Y. N.} and V. Merino and Guy, {R. H.}",

note = "Funding Information: Financial support was provided by Novartis (Basel), Becton-Dickinson, and Electricit{\'e} de France. ",

year = "1998",

month = apr,

day = "1",

doi = "10.1016/S0733-8635(05)70011-5",

language = "English",

volume = "16",

pages = "289--299",

journal = "Dermatologic Clinics",

issn = "0733-8635",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Transdermal drug delivery

T2 - Clinical aspects

AU - Kalia, Y. N.

AU - Merino, V.

AU - Guy, R. H.

N1 - Funding Information: Financial support was provided by Novartis (Basel), Becton-Dickinson, and Electricité de France.

PY - 1998/4/1

Y1 - 1998/4/1

N2 - The delivery of drugs into and through the skin is a recognized and effective means of therapy for dermatologic, regional, and systemic disease. The selection of drug candidates and the rational design of suitable formulations depends upon the biological make-up of the skin's barrier, and the physicochemical interactions between the membrane, the delivery system technology, and the active agent. This article summarizes the state of the art and examines more recent developments that are the subject of considerable research at this time. In addition, the potential to use the skin as a portal for noninvasive clInical chemistry (e.g., for glucose monitoring in diabetics) is discussed.

AB - The delivery of drugs into and through the skin is a recognized and effective means of therapy for dermatologic, regional, and systemic disease. The selection of drug candidates and the rational design of suitable formulations depends upon the biological make-up of the skin's barrier, and the physicochemical interactions between the membrane, the delivery system technology, and the active agent. This article summarizes the state of the art and examines more recent developments that are the subject of considerable research at this time. In addition, the potential to use the skin as a portal for noninvasive clInical chemistry (e.g., for glucose monitoring in diabetics) is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0031924387&partnerID=8YFLogxK

U2 - 10.1016/S0733-8635(05)70011-5

DO - 10.1016/S0733-8635(05)70011-5

M3 - Article

C2 - 9589202

AN - SCOPUS:0031924387

SN - 0733-8635

VL - 16

SP - 289

EP - 299

JO - Dermatologic Clinics

JF - Dermatologic Clinics

IS - 2

ER -

Transdermal drug delivery: Clinical aspects

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this